Skip to main content
Premium Trial:

Request an Annual Quote

Science's Hedge Fund Problem

The New England Journal of Medicine and other journals may soon require that researchers tell editors of any payments they've received from hedge funds before their work is published, says Bloomberg News' Alex Nussbaum. Existing rules on disclosing payments from drug and device companies don't cover investor money, Nussbaum says, and editors from NEJM, JAMA, and 12 others are getting together in June to talk about how to rectify this omission. The issue surfaced in November when French researcher Yves Benhamou leaked information about a drug study being conducted by Human Genome Sciences — the company he was advising at the time — to a hedge fund investing in the company, Nussbaum says.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.